How Much Did Mclab Raise?
Funding & Key Investors

Mclab, a prominent player in the life sciences sector, has successfully secured a significant capital injection, bringing its cumulative financing to $150K. This latest major strategic investment of $150K underscores the company's robust trajectory within the competitive biotechnology landscape. By leveraging this influx of resources, Mclab is well-positioned to accelerate its operational capabilities and expand its footprint in the high-growth genomics and proteomics markets.

What is Mclab?

Mclab
Business ServicesResearch & DevelopmentHealth & Nutrition Products

Based in South San Francisco, Molecular Cloning Laboratories (MCLAB) operates as a critical infrastructure provider for the life sciences industry. The company specializes in a comprehensive suite of molecular biology services, including advanced DNA sequencing, PCR cloning, and Next-Generation Sequencing (NGS). Beyond its service-oriented model, Mclab maintains a sophisticated product portfolio that encompasses enzymes, nucleic acid purification kits, and protein purification solutions. By providing essential reagents and analytical tools, the firm serves as a foundational partner for researchers and professionals engaged in complex genetic manipulation and diagnostic development. Its strategic location in the heart of the Bay Area biotech hub allows it to maintain close proximity to leading academic institutions and pharmaceutical innovators, ensuring its offerings remain at the cutting edge of scientific discovery.

How much funding has Mclab raised?

Mclab has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in Mclab

PPP

Public-Private Partnership

What's next for Mclab?

With the successful closure of this late-stage funding round, Mclab is poised to transition into a phase of aggressive market scaling and technological refinement. The strategic deployment of this capital will likely focus on enhancing the throughput of its NGS services and expanding its proprietary product lines to meet the increasing global demand for high-precision genetic analysis. As the biotechnology sector continues to prioritize rapid, accurate, and scalable laboratory solutions, Mclab's commitment to quality and technical excellence positions it to capture additional market share. Future growth initiatives will likely involve the integration of automated laboratory workflows and the potential expansion of its distribution network to support international research collaborations, further cementing its status as a vital component of the global life sciences supply chain.

See full Mclab company page
See More Financial Insights
No matching results.
Refine your search.

Frequently Asked Questions Regarding Mclab Financial Insights

What are the most recent funding rounds that Mclab has completed, and what were the funding rounds?
Mclab has recently completed 1 funding rounds: Debt on May 4, 2020.
What is the total amount of funding Mclab has raised to date?
Mclab has raised a total of $150K in funding to date.
How many funding rounds has Mclab completed?
Mclab has completed 1 funding rounds.
How much funding did Mclab raise in its most recent funding round?
Mclab raised $150K in its most recent funding round.
Who are the lead investors in Mclab's latest funding round?
The lead investor in Mclab's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Mclab's history?
The largest funding round in Mclab's history was $150K.
See more information about Mclab